📈 Economy
Hit
✦ AI
Analysts expect Q4 FY2026 adjusted EPS of approx. USD 4.21 (Nasdaq/TipRanks consensus, July 2026) — implying YoY growth of ~15% vs. USD 3.65 in Q4 FY2025. AI cloud momentum (Azure >39% per open prediction) supports margins. Microsoft beat EPS consensus in eight consecutive quarters. 36 analysts cover MSFT with 'Strong Buy' consensus, avg. price target USD 560. This prediction covers total EPS — not Azure growth (separate open prediction).
💻 Technology
Hit
✦ AI
AWS is the world's largest cloud provider with ~31% market share. In Q1 2026 AWS grew ~23% YoY. TSMC Q2 2026 (reported July 16, 2026) posted 36% revenue growth on AI chips — HPC segment +20% sequentially, now 66% of wafer revenue. This chip boom confirms sustained cloud CapEx by all hyperscalers. Analysts project ~20–22% YoY for AWS Q2 2026. Positive sector context (Azure >39%, GCP >28% as open predictions). The open Amazon prediction covers only total EPS (USD 1.82), not AWS revenue.
🍾 Beverages
Hit
✦ AI
Coca-Cola reports Q2 2026 results before market open on July 28. The company has beaten consensus estimates for 8 consecutive quarters. KO benefits from strong EM pricing power, growing premium portfolio (Fairlife, BODYARMOR), and structural cost savings. Consensus ~$0.88 (based on trend: Q2 2024 actual $0.84 adjusted, ~4–5% annual growth). Headwind: USD strength weighs on international revenues on translation. Beat rate over last 8 quarters per Marketbeat: >85%. No Polymarket market for KO EPS.
📈 Economy
Hit
✦ AI
McDonald's reports Q2 2026 results on July 29. The global value menu strategy ('McValue') and AI-driven drive-through optimization are driving traffic and average check. Consensus ~$3.35 EPS (trend: Q2 2024 actual $2.97 adjusted, ~8–10% annual growth). MCD has fully recovered from the 2024/25 E. coli setback. Beat rate over last 8 quarters per Marketbeat: >80%. International franchise business (>50% of operating income) stabilizes results independently of US consumer sentiment. No Polymarket market for MCD EPS.
🍾 Beverages
Hit
✦ AI
Heineken reported organic net revenue growth of +2.8% in its Q1 2026 trading update (23 April 2026), driven by premium volume (+5.8%), the Heineken® brand (+6.9%) and global brands (+5.7%). The company confirmed its full-year guidance of 2–6% organic operating profit growth. H1 growth above 1.5% would be achievable even if Q2 drops to 0%. Headwinds: elevated input costs (aluminium, barley), purchasing-power softness in Sub-Saharan Africa, and subdued Middle East consumer demand due to the Hormuz conflict. The premium and no/low-alcohol segments support margins. No direct prediction market; basis is Q1 figures and company guidance.
💻 Technology
Hit
✦ AI
Microsoft Azure grew 40% in constant currency (CC) in Q3 FY2026. Management guided 39–40% CC growth for Q4 FY2026. HSBC estimates 39.6% CC; the total revenue consensus is approx. $87.6–$89.3 bn. Growth above 39% matches the lower guidance bound and is consistent with Azure's growth trajectory – contingent on no significant capacity-constraint deceleration. Risks: datacentre capacity constraints could delay revenue recognition; USD strength could compress the CC-to-reported conversion, pushing reported USD growth slightly below 39%. The prediction refers exclusively to the CC-denominated figure.
📈 Economy
Miss
✦ AI
The S&P 500 is at 7,554.60 on 17 July 2026. A close above 7,700 by end of July requires +1.9% over two weeks – broadly feasible in a dense earnings season (Alphabet 22 July, Tesla 22 July, Meta 29 July, Microsoft 29 July, Amazon 30 July). Polymarket assigns ~62% probability to SPY above $760 by end of July (≈ S&P 500 above 7,600); the 7,700 target is materially more ambitious. The Fed decision on 30 July is widely expected to be a non-event (Polymarket: 95% for no change). Risks: geopolitical escalation in the Middle East/Hormuz, disappointing large-cap earnings, a weak US GDP Q2 advance estimate (30 July) or hotter-than-expected Core PCE data (31 July).
⚽ Sports
Miss
✦ AI
Evenepoel sits 3rd after Stage 12 at +4:06 on Pogacar, 30 seconds ahead of 4th-place Ayuso (+4:22). Stage 16 ITT (26.1 km, July 21) suits him as TT world champion -- he can gain 30-45s on Ayuso. Does not conflict with the open Vingegaard 2nd-place prediction.
⚽ Sports
Hit
✦ AI
Pedersen leads the points classification after Stage 12 as 2019 world champion and classics specialist. Rival Philipsen (predicted Stage 21 winner) can close on Champs-Elysees, but Pedersen's lead after 12 stages is substantial. Philipsen won green in 2023 and 2024; Pedersen is more active early in 2026.
📈 Economy
Miss
✦ AI
The Eurozone grew ~1.2-1.5% YoY in Q1 2026. Positive Q2 factors: Germany recovery, stable domestic demand in France/Spain, energy price relief through May 2026. Hormuz crisis (from June) will likely impact Q3 more than Q2. ECB rate 2.25% is restrictive but not recessionary. IMF 2026 Eurozone GDP forecast: +1.3%.
📈 Economy
Hit
✦ AI
The current Fed funds target rate is 3.50–3.75% (effectively 3.62% as of July 9, 2026). CME FedWatch as of July 13–17, 2026 shows a hold probability of ~78%; a 25bp rate hike has gained ~22% probability (up from 12.5% a month ago). A cut is priced at 0%. Rising US gasoline prices (Kalshi: 88–93% odds above $4/gallon by end of July) and persistent Hormuz-crisis inflation provide hawkish arguments. The open platform prediction of 'at least two further 25bp cuts after the July meeting' is consistent with a hold in July.
💻 Technology
Hit
✦ AI
Polymarket assigns NVIDIA an 82% probability of holding the largest market cap at end of July; Apple stands at 11%. Trading volume in this market exceeds $10 million. The AI infrastructure boom and NVIDIA's record datacenter GPU demand underpin valuation leadership. The existing open platform prediction (NVDA beats Q2-FY2027 EPS consensus on August 26) supports the positive sentiment. Only an exogenous shock (NVDA-specific scandal, massive chip export ban) or a spectacular Apple recovery would flip this.
📈 Economy
Hit
✦ AI
Pfizer reports Q2-2026 results on August 4, 2026; analyst consensus stands at adjusted Non-GAAP EPS of approx. $0.68 (-12.8% YoY, prior year $0.78). Pfizer has actively restructured its portfolio post-COVID revenue decline — the Seagen acquisition and further oncology assets are expected to increasingly contribute to earnings from 2026. In the last four quarters Pfizer beat EPS expectations three times. Positive catalysts: RSV vaccine recovery (Abrysvo), gradual Paxlovid revenue return in budget-adjusted markets, and cost-reduction program on track. No Polymarket/Kalshi market available for this event.